In an otherwise healthy adult with a confirmed renal stone and no infection, obstruction, or impaired renal function, what is the first‑line outpatient management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Outpatient Management of Nephrolithiasis

For an otherwise healthy adult with a confirmed renal stone and no infection, obstruction, or impaired renal function, first-line outpatient management consists of increased fluid intake to achieve at least 2 liters of urine output daily, combined with pain control using NSAIDs and observation for spontaneous passage if the stone is ≤10 mm. 1

Initial Assessment and Risk Stratification

Determine Stone Size and Location

  • Stones <5 mm: Expect spontaneous passage in most cases without intervention 2, 3
  • Stones 5-10 mm: Up to 50% may require intervention, but initial conservative management is appropriate 3
  • Stones >10 mm: Unlikely to pass spontaneously and should be discussed with urology 3, 4

Confirm Absence of Urgent Indications

Before proceeding with outpatient management, verify:

  • No signs of infection or sepsis (fever, purulent urine) - these require urgent drainage 5, 6
  • No complete obstruction with impaired renal function - requires urgent intervention 6
  • Pain is controllable with oral medications 4

First-Line Conservative Management

Fluid Intake (Cornerstone of Therapy)

  • Increase fluid intake throughout the day to achieve at least 2 liters of urine output daily (weak recommendation, low-quality evidence) 1
  • This reduces urinary concentration of stone-forming substances and facilitates stone passage 1

Pain Management

  • NSAIDs are first-line analgesics: Diclofenac 50-100 mg rectally or 75 mg IM is reasonable first choice 3
  • Combination of diclofenac, paracetamol, and/or codeine can provide adequate control 3
  • Opioids are less effective and worsen nausea, but use if NSAIDs contraindicated 3

Medical Expulsive Therapy

  • Alpha-blockers may facilitate stone passage, particularly for ureteral stones 5
  • Consider for stones 5-10 mm to increase spontaneous passage rates 4

Follow-up Imaging

  • Obtain follow-up imaging within 14 days to monitor stone position and assess for hydronephrosis 4
  • Plain film KUB can be used for radiopaque stones 3

When Conservative Management Fails

Indications for Urologic Referral

  • Failed medical expulsive therapy after 4-6 weeks 6
  • Uncontrolled pain despite combination analgesics 3, 4
  • Stone >10 mm at initial diagnosis 3, 4
  • Patient preference for earlier definitive intervention 6

Common Pitfall to Avoid

Do not delay urologic referral beyond 4-6 weeks of failed conservative management, as complete obstruction beyond this timeframe risks irreversible kidney injury 6

Prevention of Recurrence

For All Patients After First Stone

  • Maintain increased fluid intake to achieve at least 2 L urine output daily (weak recommendation, low-quality evidence) 1
  • Limit sodium intake to approximately 2,300 mg per day 5
  • Ensure dietary calcium consumption of 1,000-1,200 mg per day (do not restrict calcium) 5
  • Reduce soft-drink consumption (low-strength evidence for benefit) 1

For Patients with Recurrent Stones

If increased fluid intake fails to prevent recurrence:

  • Add pharmacologic monotherapy with thiazide diuretic, citrate, or allopurinol (weak recommendation, moderate-quality evidence) 1
  • Thiazides reduce recurrence risk (RR 0.52,95% CI 0.39-0.69) 1
  • Citrates reduce recurrence risk (RR 0.25,95% CI 0.14-0.44) 1
  • Allopurinol reduces recurrence risk (RR 0.59,95% CI 0.42-0.84), though benefit appears limited to patients with hyperuricemia or hyperuricosuria 1

Metabolic Evaluation

  • Perform 24-hour urine metabolic testing in high-risk patients or those with recurrent stones to identify modifiable risk factors 5
  • Stone analysis is mandatory to guide prevention strategies 5

Natural History and Prognosis

  • Spontaneous passage occurs in approximately 29% of asymptomatic stones during follow-up 7
  • 50% of patients develop symptoms by 19 months after diagnosis 7
  • 5-year recurrence rate is 35-50% without specific preventive treatment 1, 8
  • Male gender, younger age, and history of prior stones increase risk of stone-related events 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Kidney Stones: Treatment and Prevention.

American family physician, 2019

Guideline

Treatment of Lower Pole Kidney Stone Causing Pain

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Indications for Kidney Stone Surgery

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Kidney stones.

Nature reviews. Disease primers, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.